Inflammatory Biomarker Changes and Their Correlation with Framingham Cardiovascular Risk and Lipid Changes in Antiretroviral-Naive HIV-Infected Patients Treated for 144 Weeks with Abacavir/Lamivudine/Atazanavir with or without Ritonavir in ARIES

Propensity for developing coronary heart disease (CHD) is linked with Framingham-defined cardiovascular risk factors and elevated inflammatory biomarkers. Cardiovascular risk and inflammatory biomarkers were evaluated in ARIES, a Phase IIIb/IV clinical trial in which 515 antiretroviral-naive HIV-inf...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Young, Benjamin, Squires, Kathleen E., Ross, Lisa L., Santiago, Lizette, Sloan, Louis M., Zhao, Henry H., Wine, Brian C., Pakes, Gary E., Margolis, David A., Shaefer, Mark S.
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2013
Matèries:
Outcomes Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3698667/
https://ncbi.nlm.nih.gov/pubmed/23039030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2012.0278
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars